Sorrento’s and Yuhan’s Joint Venture, ImmuneOncia, receives Approval to begin clinical trial of Anti-PD-L1 Biotech Investing
Paratek Completes Submission of New Drug Applications to U.S. Food and Drug Administration Pharmaceutical Investing
AMAG Pharmaceuticals Announces FDA Approval of Supplemental New Drug Application for Feraheme Pharmaceutical Investing
MediciNova Announces MN-166 (ibudilast) Demonstrated a 26% Reduction in Confirmed Disability Progression Biotech Investing
Precision Therapeutics, Formerly Skyline Medical, Announces Stock Ticker Symbol Change to AIPT Biotech Investing
Adamas Announces Publication of ADS-5102 Phase 2 Clinical Trial Results in Multiple Sclerosis Journal Pharmaceutical Investing
Gemphire Announces Initiation of Phase 2a Clinical Trial of Gemcabene in Pediatric Non-Alcoholic Fatty Liver Disease Biotech Investing
